EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders

Yadong Zheng iD, Laura Bonfili iD, Tao Wei, Anna Maria Eleuteri iD

Nutrients · 31.10.2023 · 15 (21) · 4631

DOI: 10.3390/nu15214631 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 31.10.2023. Verfasst von Yadong Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Gastrointestinal Microbiome, Alzheimer Disease, Parkinson Disease. Die Arbeit wurde bisher 181-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Camerino, University of Camerino and the Zhongyuan Science and Technology Innovation Leading Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut–brain axis (GBA) is a complex bidirectional communication network connecting the gut and brain. It involves neural, immune, and endocrine communication pathways between the gastrointestinal (GI) tract and the central nervous system (CNS). Perturbations of the GBA have been reported in many neurodegenerative disorders (NDDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), among others, suggesting a possible role in disease pathogenesis. The gut microbiota is a pivotal component of the GBA, and alterations in its composition, known as gut dysbiosis, have been associated with GBA dysfunction and neurodegeneration. The gut microbiota might influence the homeostasis of the CNS by modulating the immune system and, more directly, regulating the production of molecules and metabolites that influence the nervous and endocrine systems, making it a potential therapeutic target. Preclinical trials manipulating microbial composition through dietary intervention, probiotic and prebiotic supplementation, and fecal microbial transplantation (FMT) have provided promising outcomes. However, its clear mechanism is not well understood, and the results are not always consistent. Here, we provide an overview of the major components and communication pathways of the GBA, as well as therapeutic approaches targeting the GBA to ameliorate NDDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesGastrointestinal MicrobiomeAlzheimer DiseaseParkinson DiseaseHumansBrain-Gut AxisBrainDysbiosis

Stichwörter der Autor:innen

gut dysbiosisgut microbiotagut–brain axisneurodegenerative disordersprobiotics

Autor:innen und Institutionen

  • School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy.
  • School of Food and Biological Engineering, Zhengzhou University of Light Industry, Zhengzhou 450002, China.

ORCID-Profile: Yadong Zheng, Laura Bonfili, Anna Maria Eleuteri

Förderung

  • University of Camerino
  • University of Camerino and the Zhongyuan Science and Technology Innovation Leading Talent Project

Zitieren

APA

Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M. (2023). Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders. Nutrients, 15(21), 4631. https://doi.org/10.3390/nu15214631

Vancouver

Zheng Y, Bonfili L, Wei T, Eleuteri AM. Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders. Nutrients. 2023;15(21):4631. doi:10.3390/nu15214631

BibTeX
@article{Zheng2023,
  author = {Zheng, Yadong and Bonfili, Laura and Wei, Tao and Eleuteri, Anna Maria},
  title = {Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {21},
  pages = {4631},
  doi = {10.3390/nu15214631}
}
Kostenlos starten →